| Literature DB >> 1446802 |
B J Bradley1, K Haskins, F G La Rosa, K J Lafferty.
Abstract
A panel of CD4+ T-cell clones has been isolated from the spleen and lymph nodes of diabetic NOD mice. These clones have been shown to be islet-specific both in vivo and in vitro. One of the clones, BDC-6.9, initiates extensive damage to islet tissue when placed adjacent to an NOD islet graft that has been used to reverse diabetes in (CBA x NOD)F1 recipients or when injected intraperitoneally into such animals. In this study, we show that BDC-6.9 T cells can initiate islet destruction in the absence of detectable CD8 T cells either in the periphery or in the lesion that develops after the transfer of the cloned islet-reactive T cells.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1446802 DOI: 10.2337/diab.41.12.1603
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461